Assessment of the renal angina index in patients hospitalized in a cardiac intensive care unit.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 Jan 2024
Historique:
received: 19 04 2023
accepted: 30 12 2023
medline: 4 1 2024
pubmed: 4 1 2024
entrez: 3 1 2024
Statut: epublish

Résumé

The renal angina index (RAI) is a validated scoring tool for predicting acute kidney injury (AKI). We investigated the efficacy of the RAI in 2436 heterogeneous patients (mean age, 70 years) treated in cardiac intensive care units (CICUs). The RAI was calculated from creatinine and patient condition scores. AKI was diagnosed by the Kidney Disease: Improving Global Outcome criteria. The primary and secondary endpoints were the development of severe AKI and all-cause mortality, respectively. Four hundred thirty-three patients developed AKI, 87 of them severe. In multivariate analyses, the RAI was a significant independent predictor of severe AKI. During the 12-month follow-up period, 210 patients suffered all-cause death. Elevated RAI was independently associated with all-cause mortality, as was NT-proBNP (p < 0.001). The RAI is a potent predictor not only of severe AKI but also of adverse outcomes and substantially improved the 12-month risk stratification of patients hospitalized in CICUs.

Identifiants

pubmed: 38168588
doi: 10.1038/s41598-023-51086-0
pii: 10.1038/s41598-023-51086-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75

Informations de copyright

© 2024. The Author(s).

Références

Basu, R. K. et al. Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int. 85, 659–667 (2014).
doi: 10.1038/ki.2013.349 pubmed: 24048379
Basu, R. K., Kaddourah, A. & Goldstein, S. L. Assessment of a renal angina index for prediction of severe acute kidney injury in critically ill children: A multicentre, multinational, prospective observational study. Lancet Child Adolesc. Health. 2, 112–120 (2018).
doi: 10.1016/S2352-4642(17)30181-5 pubmed: 30035208 pmcid: 6053052
Matsuura, R. et al. Use of the renal angina index in determining acute kidney injury. Kidney Int. Rep. 3, 677–683 (2018).
doi: 10.1016/j.ekir.2018.01.013 pubmed: 29854976 pmcid: 5976819
Ortega-Hernández, J. et al. Acute coronary syndrome and acute kidney injury: Role of inflammation in worsening renal function. BMC Cardiovasc. Disord. 17, 202 (2017).
doi: 10.1186/s12872-017-0640-0 pubmed: 28747177 pmcid: 5530514
Dankova, M. et al. Novel biomarkers for prediction of acute kidney injury in acute heart failure. Bratisl Lek Listy. 121, 321–324 (2020).
pubmed: 32356427
Naruse, H. et al. Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units. Crit. Care 22, 197 (2018).
doi: 10.1186/s13054-018-2120-z pubmed: 30119691 pmcid: 6098639
Odutayo, A. et al. AKI and long-term risk for cardiovascular events and mortality. J. Am. Soc. Nephrol. 28, 377–378 (2017).
doi: 10.1681/ASN.2016010105 pubmed: 27297949
Naruse, H. et al. Urinary liver-type fatty-acid-binding protein predicts long-term adverse outcomes in medical cardiac intensive care units. J. Clin. Med. 9, 482 (2020).
doi: 10.3390/jcm9020482 pubmed: 32050627 pmcid: 7073895
Silver, S. A., Long, J., Zheng, Y. & Chertow, G. M. Cost of acute kidney injury in hospitalized patients. J. Hosp. Med. 12, 70–76 (2017).
doi: 10.12788/jhm.2683 pubmed: 28182800
Definition, A. K. I. Section 2. Kidney Int. Suppl. 2, 19–36 (2012).
doi: 10.1038/kisup.2011.32
Meeusen, J. W., Kasozi, R. N., Larson, T. S. & Lieske, J. C. Clinical impact of the refit CKD-EPI 2021 creatinine-based eGFR equation. Clin. Chem. 68, 534–539 (2022).
doi: 10.1093/clinchem/hvab282 pubmed: 35038721
Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinf. 12, 77 (2011).
doi: 10.1186/1471-2105-12-77
Menon, S. et al. Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: A prospective cohort study. Nephrol. Dial Transplant. 31, 586–594 (2016).
doi: 10.1093/ndt/gfv457 pubmed: 26908772 pmcid: 6281075
Gorga, S. M., Carlton, E. F., Kohne, J. G., Barbaro, R. P. & Basu, R. K. Renal angina index predicts fluid overload in critically ill children: an observational cohort study. BMC Nephrol. 22, 336 (2021).
doi: 10.1186/s12882-021-02540-6 pubmed: 34635072 pmcid: 8502791
Gawadia, J., Mishra, K., Kumar, M. & Saikia, D. Prediction of severe acute kidney injury using renal angina index in a pediatric intensive care unit. Indian Pediatr. 56, 647–652 (2019).
doi: 10.1007/s13312-019-1587-2 pubmed: 31477644
Holland, E. M. & Moss, T. J. Acute noncardiovascular illness in the cardiac intensive care unit. J. Am. Coll. Cardiol. 69, 1999–2007 (2017).
doi: 10.1016/j.jacc.2017.02.033 pubmed: 28427574
Na, S. J. et al. Association between presence of a cardiac intensivist and mortality in an adult cardiac care unit. J. Am. Coll. Cardiol. 68, 2637–2648 (2016).
doi: 10.1016/j.jacc.2016.09.947 pubmed: 27978948
Thakar, C. V., Worley, S., Arrigain, S., Yared, J. P. & Paganini, E. P. Improved survival in acute kidney injury after cardiac surgery. Am. J. Kidney Dis. 50, 703–711 (2007).
doi: 10.1053/j.ajkd.2007.07.021 pubmed: 17954283
Yue, S. et al. Construction and validation of a risk prediction model for acute kidney injury in patients suffering from septic shock. Dis. Mark. https://doi.org/10.1155/2022/9367873 (2022).
doi: 10.1155/2022/9367873
Palazzuoli, A. et al. Comparison of neutrophil gelatinase-associated lipocalin versus B-type natriuretic peptide and cystatin C to predict early acute kidney injury and outcome in patients with acute heart failure. Am. J. Cardiol. 116, 104–111 (2015).
doi: 10.1016/j.amjcard.2015.03.043 pubmed: 25943992
Li, X. et al. Brain natriuretic peptide for predicting contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing coronary angiography: A systematic review and meta-analysis. J. Interv. Cardiol. https://doi.org/10.1155/2020/1035089 (2020).
doi: 10.1155/2020/1035089 pubmed: 33424492 pmcid: 7775184
Fiorentino, M., Tohme, F. A., Murugan, R. & Kellum, J. A. Plasma biomarkers in predicting renal recovery from acute kidney injury in critically ill patients. Blood Purif. 48, 253–261 (2019).
doi: 10.1159/000500423 pubmed: 31079110
Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V. & Bates, D. W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16, 3365–3370 (2005).
doi: 10.1681/ASN.2004090740 pubmed: 16177006
Uchino, S. M., Kellum, J. A., Bellomo, R., Doig, G. S. & Morimatsu, H. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA. 294, 813–818 (2005).
doi: 10.1001/jama.294.7.813 pubmed: 16106006
Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis. Kidney Int. 81, 442–448 (2012).
doi: 10.1038/ki.2011.379 pubmed: 22113526
Bibbins-Domingo, K. et al. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA. 297, 169–176 (2007).
doi: 10.1001/jama.297.2.169 pubmed: 17213400 pmcid: 2848442
Groenning, B. A. et al. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart. 90, 297–303 (2004).
doi: 10.1136/hrt.2003.026021 pubmed: 14966052 pmcid: 1768111
Hartmann, F. et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110, 1780–1786 (2004).
doi: 10.1161/01.CIR.0000143059.68996.A7 pubmed: 15381643

Auteurs

Eirin Sakaguchi (E)

Department of Faculty of Medical Technology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Hiroyuki Naruse (H)

Department of Faculty of Medical Technology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. hnaruse@fujita-hu.ac.jp.

Yuya Ishihara (Y)

Department of Faculty of Medical Technology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Hidekazu Hattori (H)

Department of Faculty of Medical Technology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Akira Yamada (A)

Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Hideki Kawai (H)

Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Takashi Muramatsu (T)

Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Yoshiki Tsuboi (Y)

Department of Preventive Medical Sciences, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Ryosuke Fujii (R)

Department of Preventive Medical Sciences, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Koji Suzuki (K)

Department of Preventive Medical Sciences, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Junnichi Ishii (J)

Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Kuniaki Saito (K)

Department of Faculty of Medical Technology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Masayoshi Sarai (M)

Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Masanobu Yanase (M)

Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Yukio Ozaki (Y)

Department of Cardiology, Fujita Health University School of Medicine, Okazaki Medical Center, 1 Aza Gotanda, Harisaki-cho, Okazaki, Aichi, 444-0827, Japan.

Hideo Izawa (H)

Department of Cardiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

Classifications MeSH